NCT00357747 2023-08-04
AEG35156 and Docetaxel in Treating Patients With Solid Tumors
Canadian Cancer Trials Group
Phase 1 Completed
Clinical Trials
7 trialsNCT00372736 2023-08-04
AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors
Canadian Cancer Trials Group
Phase 1 Completed
NCT01018069 2011-07-13
AEG35156 in Combination With High-dose Cytarabine and Idarubicin in AML Following Failure of a Single Standard Dose Cytarabine Based Frontline Induction Regimen
Aegera Therapeutics
Phase 2 Terminated
NCT00558545 2009-12-02
A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer
Aegera Therapeutics
Phase 1/2 Terminated
NCT00557596 2009-12-01
A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer
Aegera Therapeutics
Phase 1/2 Terminated
NCT00558922 2009-07-30
A Phase 1-2 XIAP Antisense AEG35156 With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
Aegera Therapeutics
Phase 1/2 Terminated
NCT00385775 2008-08-21
Study of XIAP Antisense for Advanced Cancers
Aegera Therapeutics
Phase 1 Terminated